Ellagic Acid Inhibits Trichophyton rubrum Growth via Affecting Ergosterol Biosynthesis and Apoptotic Induction

Zhi-Jian Li1, Amima Abula1, Abudumijiti Abulizi2

  • 1Department of Toxicology Laboratory, Xinjiang Institute of Traditional Uyghur Medicine, Urumqi, Xinjiang 830049, China.

Abstract

Insights

Ellagic acid (EA) and shikonin (SK) demonstrate potent antifungal activity against Trichophyton rubrum by damaging cell membranes and inhibiting ergosterol biosynthesis. These natural compounds show promise for developing new antifungal treatments.

Area of Science:

  • Mycology
  • Natural Product Chemistry
  • Dermatology

Background:

  • *Trichophyton rubrum* is a primary cause of superficial fungal infections like onychomycosis and tinea pedis, particularly in vulnerable populations.
  • Ellagic acid (EA) and shikonin (SK) are natural compounds with known bioactivities, including antifungal properties, but their specific mechanisms against *T. rubrum* remain unelucidated.

Purpose of the Study:

  • To evaluate the antifungal efficacy of Ellagic acid (EA) and shikonin (SK) against *Trichophyton rubrum*.
  • To elucidate the molecular mechanisms underlying the antifungal action of EA and SK.

Main Methods:

  • Investigated the effects of varying doses of EA and SK on *T. rubrum* viability and cell structure using scanning electron microscopy (SEM).
  • Assessed fungal cell apoptosis and necrosis via flow cytometry and analyzed the expression of key ergosterol biosynthesis pathway genes (e.g., MEP4, SUB1) using qPCR.

Main Results:

  • SEM revealed significant damage to *T. rubrum* cell surfaces, including shrinkage, folding, peeling, and cell content leakage after EA and SK treatment.
  • EA and SK significantly increased fungal cell apoptosis rates in a dose-dependent manner.
  • qPCR analysis indicated a downregulation of MEP4 and SUB1 gene expression in response to EA and SK treatment.

Conclusions:

  • EA and SK exhibit antifungal activity against *T. rubrum* by disrupting the fungal cell membrane.
  • The mechanism involves the inhibition of ergosterol biosynthesis, specifically C14 demethylase and squalene epoxidase activity, through the downregulation of MEP4 and SUB1.
  • EA and SK represent potential natural antifungal agents for future clinical applications.